Naked DNA Transfer of Factor VIII Induced Transgene-Specific, Species-Independent Immune Response in Hemophilia A Mice

This publication has 43 references indexed in Scilit:

• High-Level Factor VIII Gene ExpressionIn VivoAchieved by Nonviral Liver-Specific Gene Therapy Vectors
  Human Gene Therapy, 2003
• Structure and Function of the Factor VIII Gene and Protein
  Seminars in Thrombosis and Hemostasis, 2003
• Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors
  Blood, 2003
• The Canine Factor VIII 3′-Untranslated Region and a Concatemeric Hepatocyte Nuclear Factor 1 Regulatory Element Enhance Factor VIII Transgene ExpressionIn Vivo
  Human Gene Therapy, 2002
• Influence of Vector Dose on Factor IX-Specific T and B Cell Responses in Muscle-Directed Gene Therapy
  Human Gene Therapy, 2002
• Muscle-Directed Gene Transfer and Transient Immune Suppression Result in Sustained Partial Correction of Canine Hemophilia B Caused by a Null Mutation
  Molecular Therapy, 2001
• Risk and Prevention of Anti-factor IX Formation in AAV-Mediated Gene Transfer in the Context of a Large Deletion of F9
  Molecular Therapy, 2001
• Generation and Characterization of E1/E2a/E3/E4-Deficient Adenoviral Vectors Encoding Human Factor VIII
  Molecular Therapy, 2001
• Role of Vector in Activation of T Cell Subsets in Immune Responses against the Secreted Transgene Product Factor IX
  Molecular Therapy, 2000
• Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A
  Nature Genetics, 1995